As of 2025-10-19, the Relative Valuation of Rigel Pharmaceuticals Inc (RIGL) is 44.60 USD. This relative valuation is based on P/E multiples. With the latest stock price at 27.94 USD, the upside of Rigel Pharmaceuticals Inc based on Relative Valuation is 59.6%.
The range of the Relative Valuation is 18.22 - 71.76 USD.
| Range | Selected | |
| Trailing P/E multiples | 11.5x - 13.2x | 12.4x |
| Forward P/E multiples | 18.8x - 26.3x | 22.6x |
| Fair Price | 18.22 - 71.76 | 44.60 |
| Upside | -34.8% - 156.8% | 59.6% |
| Date | P/E |
| 2025-10-16 | 5.16 |
| 2025-10-15 | 5.16 |
| 2025-10-14 | 5.02 |
| 2025-10-13 | 4.92 |
| 2025-10-10 | 5.17 |
| 2025-10-09 | 5.21 |
| 2025-10-08 | 5.27 |
| 2025-10-07 | 5.41 |
| 2025-10-06 | 5.30 |
| 2025-10-03 | 5.23 |
| 2025-10-02 | 5.16 |
| 2025-10-01 | 5.16 |
| 2025-09-30 | 5.20 |
| 2025-09-29 | 5.27 |
| 2025-09-26 | 5.25 |
| 2025-09-25 | 5.26 |
| 2025-09-24 | 5.55 |
| 2025-09-23 | 6.24 |
| 2025-09-22 | 6.32 |
| 2025-09-19 | 6.37 |
| 2025-09-18 | 6.44 |
| 2025-09-17 | 6.28 |
| 2025-09-16 | 6.42 |
| 2025-09-15 | 6.84 |
| 2025-09-12 | 6.96 |
| 2025-09-11 | 6.94 |
| 2025-09-10 | 6.69 |
| 2025-09-09 | 6.59 |
| 2025-09-08 | 7.50 |
| 2025-09-05 | 7.58 |
| 2025-09-04 | 7.36 |
| 2025-09-03 | 7.26 |
| 2025-09-02 | 7.05 |
| 2025-08-29 | 7.12 |
| 2025-08-28 | 7.21 |
| 2025-08-27 | 7.29 |
| 2025-08-26 | 7.63 |
| 2025-08-25 | 7.47 |
| 2025-08-22 | 7.61 |
| 2025-08-21 | 7.70 |
| 2025-08-20 | 7.59 |
| 2025-08-19 | 7.14 |
| 2025-08-18 | 7.35 |
| 2025-08-15 | 7.25 |
| 2025-08-14 | 6.95 |
| 2025-08-13 | 6.71 |
| 2025-08-12 | 6.33 |
| 2025-08-11 | 6.14 |
| 2025-08-08 | 5.81 |
| 2025-08-07 | 5.58 |